Researchers in the US have shown that an artificial intelligence algorithm trained to analyse video recordings of sleep tests ...

In October, Intellia reported phase 2 results with NTLA-2002 – which is pitching to become the first approved in vivo CRISPR ...

A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today with ...

Bioanalysis is also used to monitor therapeutic responses by evaluating drug levels, biomarkers, and physiological changes ...

Investor interest in companies with obesity candidates in their pipeline clearly remains high, given that a brand new ...

In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical ...

In conclusion, I see 2025 as a year in which the patient will still be centre-stage. But, in order for that to happen ...

This tiered approach allows investors to engage at the level they’re most comfortable with, sparking their interest with a ...

The UK's Poolbeg Pharma has disclosed that it is in talks over a possible takeover by Hookipa, an Austrian biotech that is listed on the Nasdaq.

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Through a series of position papers, the EFPIA representing brandname drugmakers, self-medication group organisation AESGP, and Medicines for Europe – which represents the generic pharma industry – ...

According to the paper by researchers at the University of Bath in the UK and Lund University in Sweden, the self-regulated Disclosure UK system operated by the Association of the British ...